Clinical Trial Update: Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing remimazolam and etomidate as induction agents for electroconvulsive therapy has completed, potentially informing anesthetic choices in E…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Etomidate (etomidate)
• Remimazolam (remimazolam)

Snippet

Sponsor: Yeongseok Yun | Conditions: Schizophenia Disorder, Major Depression Disorders | Phase 4 | Status: COMPLETED